Sales and Marketing

Scientists in The Netherlands have detailed a possible correlation between COVID-19 and the onset of Parkinson’s disease. The findings may …

Sotrovimab, commercially known as Xevudy, is now available on the NHS to reduce the risk of vulnerable patients needing hospitalisation …

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …

Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …

A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …

The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …

Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …

Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …

Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …

Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …

A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …

WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …